Trials / Unknown
UnknownNCT03583476
The Impact of Antibiotics MIC Value on the Efficacy of Treatment Regimens for Helicobacter Pylori Infection.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,821 (estimated)
- Sponsor
- National Taiwan University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
Clarithromycin (CLA)、amoxicillin (AMO)、metronidazole (MET)、levofloxacin (LEV) and tetracycline (TET) are commonly used antibiotics for Helicobacter pylori (Hp) therapy. However, the efficacy of treatment for Helicobacter pylori infection has decreased due to increasing resistance to CLA, MET and LEV. Studies had reported that beside antibiotics resistance, other factors such as age, sex, underlying disease, etc. may also affect the treatment efficacy. In some cases, when the MIC values were beyond the breakpoint, H. pylori strains with lower MIC value had better eradication than the ones with higher MIC value. However, few study investigated the relationship between MIC values and treatment outcome. The investigators aimed to analyze the impact of influencing factors, especially minimal inhibitory concentration (MIC) value, on the efficacy of different treatment regimens.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Proton pump inhibitor,clarithromycin,amoxicillin or metronidazole | Triple or quadruple therapy consist of Proton pump inhibitor,clarithromycin,amoxicillin or metronidazole. |
Timeline
- Start date
- 2018-04-01
- Primary completion
- 2018-12-31
- Completion
- 2018-12-31
- First posted
- 2018-07-11
- Last updated
- 2018-07-11
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT03583476. Inclusion in this directory is not an endorsement.